Sort
141,003 grants matching “cytokine”
Physicochemical Cues and Their Roles in the Angiogenic Switch
$1,029,290Claudia Fischbach · Cornell University · U54 · FY2013 · CA
GuMI: New In Vitro Platforms to Parse the Human Gut Epithelial-Microbiome-Immune Axis
$1,028,858Rebecca L Carrier · Northeastern University · R01 · FY2017 · EB
TNF Signaling and Cell Death
$1,028,569Zheng-Gang Liu · Division Of Clinical Sciences - Nci · ZIA · FY2013 · CA
Mechanisms of varicella virus-induced multisystem disease using a primate model
$1,028,474Ravi Mahalingam · University Of Colorado Denver · P01 · FY2019 · AG
INDâenabling development of MMâ008 IVR, an antibody-based nonhormonal contraceptive intravaginal ring
$1,028,445Richard A Cone · Mucommune, Llc · R44 · FY2023 · HD
Immune reconstitution following autologous and allogeneic stem cell transplant
$1,028,281Francis Flomerfelt · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA
CLINICAL INVESTIGATION OF ACTIVE SPECIFIC IMMUNOTHERAPY OF MALIGNANT MELANOMA
$1,027,837John Wayne Cancer Institute · P01 · FY2000 · CA
CORE--SERUM, LYMPHOCYTE AND TISSUE COLLECTION AND ANALYSIS
$1,027,837John Wayne Cancer Institute · P01 · FY2000 · CA
Virologic Correlates of Heterosexual Transmission
$1,027,755Eric Hunter · Emory University · R37 · FY2014 · AI
An adjuvant that promotes TH1/TH17 and CD8 T cells in a tuberculosis vaccine
$1,027,582Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2015 · AI
Impact of Pregnancy on Drug Absorption, Disposition and End Organ Response
$1,027,538Steve N Caritis · Magee-Women'S Res Inst And Foundation · U10 · FY2010 · HD
The Environmental Triggers of Diabetes (TEDDY) in Sweden
$1,027,536Ake Lernmark · Lunds Universitet · U01 · FY2009 · DK
Prophylaxis of adrenal insufficiency to prevent CLD
$1,027,275University Of New Mexico · R01 · FY2003 · HD
Studies of neurocysticercosis and animal cestode infections
$1,027,145Theodore Nash · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Biomimetic Macrophage Membrane-Coated Nanosponges: A Novel Therapeutic for Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Hospital-Associated Pneumonia
$1,027,000Victor Nizet · University Of California, San Diego · R01 · FY2023 · AI
Inflammatory Mechanisms and Treatment Strategies for Atherosclerosis in HIV
$1,026,954Steven Kyle Grinspoon · Massachusetts General Hospital · R01 · FY2011 · HL
Studies of neurocysticercosis and animal cestode infections
$1,026,875Theodore Nash · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Pathogenic differences between Cryptococcus neoformans and C. gattii
$1,026,682Kyung Kwon-Chung · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Pathogenic differences between Cryptococcus neoformans and C. gattii
$1,026,668Kyung Kwon-Chung · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
A Novel Synthetic Biology-Derived Microbiome Therapeutic to Treat Viral-Induced Acute Respiratory Distress Syndrome (ARDS)
$1,026,596Christian Furlan Freguia · Rise Therapeutics, Llc · R44 · FY2023 · AI
Immunity to Pneumonic Tularemia
$1,026,403Catharine Bosio · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
IL-15 in the immunotherapy of cancer
$1,026,376Kevin Conlon · Division Of Basic Sciences - Nci · ZID · FY2014 · CA
Protection Against Inhalation Anthrax with Inactivated Spores
$1,026,116Donald G. Guiney · University Of California, San Diego · U01 · FY2010 · AI
CENTER FOR AIDS RESEARCH (CFAR)
$1,025,955Case Western Reserve University · P30 · FY2000 · AI
Biological and lifestyle factors contributing to Tau in women at risk for Alzheimer's disease.
$1,025,931Sarah Banks · University Of California, San Diego · R01 · FY2023 · AG